Orgenesis Inc. (ORGS)
NASDAQ: ORGS · IEX Real-Time Price · USD
0.628
-0.021 (-3.19%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Orgenesis Market Cap
Orgenesis has a market cap or net worth of $29.65 million as of July 2, 2024. Its market cap has decreased by -15.03% in one year.
Market Cap
29.65M
Enterprise Value
56.92M
1-Year Change
-15.03%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since March 13, 2012, Orgenesis's market cap has decreased from $70.70M to $29.65M, a decrease of -58.06%. That is a compound annual growth rate of -6.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 22.30M | 39.38% |
| Dec 29, 2023 | 16.00M | -67.87% |
| Dec 30, 2022 | 49.80M | -28.76% |
| Dec 31, 2021 | 69.90M | -35.69% |
| Dec 31, 2020 | 108.70M | 44.36% |
| Dec 31, 2019 | 75.30M | 3.29% |
| Dec 31, 2018 | 72.90M | 24.62% |
| Dec 29, 2017 | 58.50M | 65.25% |
| Dec 30, 2016 | 35.40M | 12.74% |
| Dec 31, 2015 | 31.40M | -1.88% |
| Dec 31, 2014 | 32.00M | -2.14% |
| Dec 31, 2013 | 32.70M | 21.11% |
| Dec 31, 2012 | 27.00M | -61.81% |
| Mar 13, 2012 | 70.70M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VYNE Therapeutics | 28.62M |
| SAB Biotherapeutics | 28.61M |
| Bolt Biotherapeutics | 28.60M |
| Streamline Health Solutions | 28.58M |
| ProMIS Neurosciences | 28.44M |
| Rapid Micro Biosystems | 28.29M |
| Acasti Pharma | 27.45M |
| NeuroBo Pharmaceuticals | 27.44M |